Why the study?
Does the CURATE.AI platform predict antihypertensive treatment responses and identify optimal personalized doses in hypertension patients?
Does the CURATE.AI platform predict antihypertensive treatment responses and identify optimal personalized doses in hypertension patients?
CURATE.AI shows promise as an artificial intelligence platform to predict antihypertensive treatment responses and optimize personalized dosing in hypertension patients.
In article number 2100091, Agata Blasiak, Christopher Chen, Dean Ho, and co-workers demonstrate a promising application of CURATE.AI – a scalable, mechanism-independent and indication-agnostic artificial intelligence platform, to rapidly predict antihypertensive treatment responses and identify optimal, personalized doses for improved outcomes.
No takes yet. Share an insight, caveat, or question.
Truong et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: